MBL77 - AN OVERVIEW

Not all sufferers with CLL need therapy. Even with all the latest developments, the iwCLL continue to suggests watchful observation for patients with asymptomatic disease.86 This advice is based on not less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).MERDE